---
title: "XtalPi × Yaosu Technology: Signs Another Ten-Million-Level Partnership, Deepens 3D Bio Intelligence Layout with Anti-Aging Brand LAIFE®"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39948739.md"
description: "I. Major Event • Xellar Biosystems has officially signed a ten-million-level technical service cooperation agreement with the leading domestic anti-aging brand LAIFE®. II. Key Highlights • Both parties will utilize Xellar's EPIC™ organ-on-a-chip + AI (3D Bio Intelligence) platform to help LAIFE® conduct more scientific R&D in the anti-aging field; • The focus is on decoding longevity factors (i.e., identifying which components or mechanisms can truly combat aging), including building humanized organ-on-a-chip models for skin, blood vessels, immune system, etc..."
datetime: "2026-04-15T22:26:14.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39948739.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39948739.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39948739.md)
author: "[周树人的交易员](https://longbridge.com/en/profiles/12816038.md)"
---

# XtalPi × Yaosu Technology: Signs Another Ten-Million-Level Partnership, Deepens 3D Bio Intelligence Layout with Anti-Aging Brand LAIFE®

I. Key Event  
• Xellar Biosystems has officially signed a multi-ten-million-yuan technical service cooperation agreement with the leading domestic anti-aging brand LAIFE®.

II. Core Highlights  
• Both parties will leverage Xellar's EPIC™ organ-on-a-chip + AI (3D Bio Intelligence) platform to help LAIFE® conduct more scientific R&D in the anti-aging field;  
• The focus is on decoding longevity factors (i.e., identifying which components or mechanisms can truly combat aging), including constructing humanized organ-on-a-chip models for skin, blood vessels, immune system, etc. Through high-throughput experiments + AI analysis, the impact of nutrients/active ingredients on cellular aging, inflammation, metabolism, etc., will be studied;  
• This marks the expansion of Xellar's platform from drug R&D and nutritional science (Feihe) further into the anti-aging/longevity health field.

Thoughts: Another multi-ten-million-yuan cross-border collaboration, similar in nature to the previous nutrition cooperation with China Feihe. Xellar isn't selling its own products but rather renting out its EPIC™ platform as an advanced testing tool for others. Within just half a month, deals have been secured with Feihe (nutrition), the Korean DILI Demo Day, and AACR exhibition participation, now adding an anti-aging brand. This shows Xellar is rapidly converting its technology into revenue.

$XTALPI(02228.HK)

### Related Stocks

- [02228.HK](https://longbridge.com/en/quote/02228.HK.md)
- [06186.HK](https://longbridge.com/en/quote/06186.HK.md)